Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News THT 2026

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

Todd Neale

March 04, 2026

Presentation THT 2026

Healthcare Systems Harnessing Their Own Data for Evidence, Generation, Dissemination, and Influencing Clinical Practice — Example 2

Presenter: Nir Uriel

March 04, 2026

Presentation THT 2026

How Will Guideline Committees View Results From RWE Trials?

Presenter: Paul Heidenrich

March 04, 2026

Presentation THT 2026

AHA and C3TN Shock Networks

Presenter: Shashank Shekhar Sinha

March 04, 2026

Presentation THT 2026

Cardiogenic Shock Working Group: Triumphs and Tribulations

Presenter: Rachna Kataria

March 04, 2026

Presentation THT 2026

Hemodynamic Frontiers in Heart Failure (HF2) Registry: Goals and Achievements

Presenter: Tom Heywood

March 04, 2026

Presentation THT 2026

Virtual Randomized Clinical Trials: Learnings From DANLOGIC-HF

Presenter: Tor Biering-Sørensen

March 04, 2026

Presentation THT 2026

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Presenter: Issa Dahabreh

March 04, 2026

Presentation THT 2026

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Presenter: Robert W. Yeh

March 04, 2026

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

News Conference News THT 2025

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Todd Neale

February 11, 2025

Presentation THT 2025

Evaluating Glucagon-Like Peptide Agonists and Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Treatment in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Global RCTs

Presenter: Arvind Kumar Venkataramana Raju

February 11, 2025

Presentation THT 2025

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Presenter: Allan Böhm

February 11, 2025

Presentation THT 2022

RCTs in Cardiogenic Shock: Easier Said Than Done!

Presenter: Manreet Kanwar

February 02, 2022

Advertisement

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

Healthcare Systems Harnessing Their Own Data for Evidence, Generation, Dissemination, and Influencing Clinical Practice — Example 2

How Will Guideline Committees View Results From RWE Trials?

AHA and C3TN Shock Networks

Cardiogenic Shock Working Group: Triumphs and Tribulations

Hemodynamic Frontiers in Heart Failure (HF2) Registry: Goals and Achievements

Virtual Randomized Clinical Trials: Learnings From DANLOGIC-HF

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Evaluating Glucagon-Like Peptide Agonists and Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Treatment in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Global RCTs

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

RCTs in Cardiogenic Shock: Easier Said Than Done!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content